Eliem Therapeutics Inc (NASDAQ: ELYM) Stock Information | RedChip

Eliem Therapeutics Inc (NASDAQ: ELYM) Listen to this Section


$6.09
N/A ( 0% ) 124.0K

Eliem Therapeutics Inc is a clinical-stage biotechnology company. It is focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Its main drug candidate is ETX-155 for major depressive disorder (MDD) and focal onset seizures (FOS).

Market Data


Open


$6.09

Previous close


$6.09

Volume


124.0K

Market cap


$412.42M

Day range


$5.93 - $6.26

52 week range


$2.35 - $11.55

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Jun 27, 2024
8-k 8K-related 13 Jun 26, 2024
4 Insider transactions 1 Jun 21, 2024
8-k 8K-related 15 Jun 12, 2024
ars Annual reports 1 Jun 04, 2024
prem14a Proxies and info statements 10 May 17, 2024
10-q Quarterly Reports 59 May 15, 2024
10-k/a Quarterly Reports 16 Apr 29, 2024
8-k 8K-related 41 Apr 11, 2024
4 Insider transactions 1 Apr 08, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.